glutathione s-transferase uniprot Information on EC 2.5.1.18 - transferase and Organism(s) Homo sapiens and Accession O15217 Glutathione S Information on EC 1.1.1.213 -

Conclusion: Prior use of bile acid binding resins was low in the GLISTEN population despite its first-line position in treatment guidelines

MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited published safety data Reported well-tolerated in small Russian studies Known interactions GABAergic medications (theoretical unstudied) Benzodiazepines (theoretical additive sedation) Contraindications Pregnancy/lactation (unstudied) Hypersensitivity REGULATORY STATUS FDA Not FDA-approved

doi:10.1186/s12905-020-00930-w

In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress

Imai and Guarente, 2014), an aspect that could worsen in these diseases because of its progressive nature ( + levels have been shown to decrease with age, leading to low levels in the brain (Zhu et al., 2015)

Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation